<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 28-year-old woman with a long history of <z:e sem="disease" ids="C0013146" disease_type="Mental or Behavioral Dysfunction" abbrv="">drug abuse</z:e> experienced flaccid <z:hpo ids='HP_0002445'>quadriplegia</z:hpo> and bilateral loss of posterior column sensation a few minutes after an intravenous (IV) injection of <z:chebi fb="0" ids="31836">methylphenidate hydrochloride</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Subsequently, <z:hpo ids='HP_0001257'>spasticity</z:hpo> developed and she showed minimal functional improvement during a period of several months </plain></SENT>
<SENT sid="2" pm="."><plain>Necropsy performed 8 1/2 months later showed systemic <z:hpo ids='HP_0002955'>granulomatosis</z:hpo> due to talc and two ischemic infarctions, one involving both medial medullary areas and the other involving the left frontal lobe </plain></SENT>
<SENT sid="3" pm="."><plain>Deposits of talc, presumably from a medication prepared for oral use, were demonstrated in the small vessels in the area of the medullary infarction </plain></SENT>
<SENT sid="4" pm="."><plain>This case is unique in that the medial medullary syndrome was apparently caused by an <z:mpath ids='MPATH_110'>embolus</z:mpath> of talc following its IV administration </plain></SENT>
</text></document>